{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:24:06Z","timestamp":1790717046555,"version":"4.1.0"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011145","name":"Fashion Footwear Association of New York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011145","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nicole Meloche Memorial Breast Cancer Research Foundations"},{"name":"Penguins Alumni Foundation"},{"name":"Shear Family Foundation"},{"name":"TL-1 CTSA Pre-Doctoral Training Grant","award":["5TL1TR001116-03"],"award-info":[{"award-number":["5TL1TR001116-03"]}]},{"name":"Duke Cancer Institute Core Grant","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}]},{"name":"Magee-Womens Research Institute and Foundation"},{"DOI":"10.13039\/100005987","name":"Susan G. Komen for the Cure, Komen Wyoming Affiliate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005987","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0755-1","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T08:04:10Z","timestamp":1571385850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors"],"prefix":"10.1136","volume":"7","author":[{"given":"Li","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Narloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayali","family":"Onkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Broadwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Luedke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Pogue-Geile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sammons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naema","family":"Nayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugonma","family":"Chukwueke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey K.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Soloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario A. A.","family":"Vignali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leisha A.","family":"Emens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Oesterreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-514X","authenticated-orcid":false,"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"755_CR1","unstructured":"Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, \n                    https:\/\/seer.cancer.gov\/csr\/1975_2015\/\n                    \n                  . based on November 2017 SEER data submission, posted to the SEER web site, April 2018."},{"issue":"11","key":"755_CR2","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.1697","volume":"7","author":"Matias Riihim\u00e4ki","year":"2018","unstructured":"Riihim\u00e4ki MTH, Sundquist K, Sundquist J, Hemminki K. Clinical landscape of cancer metastases. Cancer Med. 2018. \n                    https:\/\/doi.org\/10.1002\/cam4.1697\n                    \n                  .","journal-title":"Cancer Medicine"},{"issue":"3","key":"755_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/annonc\/mdt556","volume":"25","author":"MV Dieci","year":"2014","unstructured":"Dieci MV, Criscitiello C, Goubar A, Viale G, Conte P, Guarneri V, Ficarra G, Mathieu MC, Delaloge S, Curigliano G, Andre F. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol. 2014;25(3):611\u20138. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdt556\n                    \n                  .","journal-title":"Ann Oncol"},{"issue":"1","key":"755_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jamaoncol.2015.3239","volume":"2","author":"EA Perez","year":"2016","unstructured":"Perez EA, Ballman KV, Tenner KS, Thompson EA, Badve SS, Bailey H, Baehner FL. Association of Stromal Tumor-Infiltrating Lymphocytes with Recurrence-Free Survival in the N9831 adjuvant trial in patients with early-stage HER2-positive breast Cancer. Jama Oncol. 2016;2(1):56\u201364. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2015.3239\n                    \n                  .","journal-title":"Jama Oncol"},{"issue":"3","key":"755_CR5","doi-asserted-by":"publisher","first-page":"a027128","DOI":"10.1101\/cshperspect.a027128","volume":"7","author":"Mei Zhang","year":"2017","unstructured":"Zhang M, Lee AV, Rosen JM. The cellular origin and evolution of breast Cancer. Cold Spring Harb Perspect Med. 2017;7(3). \n                    https:\/\/doi.org\/10.1101\/cshperspect.a027128\n                    \n                  .","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"11","key":"755_CR6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, Mckenna A, Chevalier A, Rosenberg M, Barker FG 2nd, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015;5(11):1164\u201377. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0369\n                    \n                  .","journal-title":"Cancer Discov"},{"issue":"5","key":"755_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaoncol.2016.5630","volume":"3","author":"N Priedigkeit","year":"2017","unstructured":"Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ, Thomas R, Leone JP, Lucas PC, Bhargava R, Hamilton RL, Chmielecki J, Puhalla SL, Davidson NE, Oesterreich S, Brufsky AM, Young L, Lee AV. Intrinsic subtype switching and acquired ERBB2\/HER2 amplifications and mutations in breast Cancer brain metastases. Jama Oncol. 2017;3(5):666\u201371. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2016.5630\n                    \n                  .","journal-title":"Jama Oncol"},{"key":"755_CR8","doi-asserted-by":"publisher","unstructured":"Priedigkeit N, Watters RJ, Lucas PC, Basudan A, Bhargava R, Horne W, Kolls JK, Fang Z, Rosenzweig MQ, Brufsky AM, Weiss KR, Oesterreich S, Lee AV. Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight. 2017;2(17). \n                    https:\/\/doi.org\/10.1172\/jci.insight.95703\n                    \n                  .","DOI":"10.1172\/jci.insight.95703"},{"issue":"2","key":"755_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1158\/1541-7786.MCR-18-0946","volume":"17","author":"Ahmed Basudan","year":"2019","unstructured":"Basudan A, Priedigkeit N, Hartmaier RJ, Sokol ES, Bahreini A, Watters RJ, Boisen MM, Bhargava R, Weiss KR, Karsten MM, Denkert C, Blohmer JU, Leone JP, Hamilton RL, Brufsky AM, Elishaev E, Lucas PC, Lee AV, Oesterreich S. Frequent ESR1 and CDK pathway copy number alterations in metastatic breast Cancer. Mol Cancer Res. 2018. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0946\n                    \n                  .","journal-title":"Molecular Cancer Research"},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. \n                    https:\/\/doi.org\/10.1038\/ncomms3612\n                    \n                  .","journal-title":"Nat Commun"},{"key":"755_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7. \n                    https:\/\/doi.org\/10.1186\/1471-2105-14-7\n                    \n                  .","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"755_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/Nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng WG, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453. \n                    https:\/\/doi.org\/10.1038\/Nmeth.3337\n                    \n                  .","journal-title":"Nat Methods"},{"issue":"1","key":"755_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon JC, Zhao HQ, Li TW, Novak J, Jiang P, Shen H, Aster JC, Rodig S, Signoretti S, Liu JS, Liu XS. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174. \n                    https:\/\/doi.org\/10.1186\/s13059-016-1028-7\n                    \n                  .","journal-title":"Genome Biol"},{"issue":"2","key":"755_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S, International TWG. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol. 2015;26(2):259\u201371. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdu450\n                    \n                  .","journal-title":"Ann Oncol"},{"issue":"6322","key":"755_CR15","doi-asserted-by":"publisher","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","volume":"355","author":"Teresa Davoli","year":"2017","unstructured":"Davoli T, Uno H, Wooten EC, Elledge SJ. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science. 2017;355(6322). \n                    https:\/\/doi.org\/10.1126\/science.aaf8399\n                    \n                  .","journal-title":"Science"},{"issue":"15","key":"755_CR16","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1158\/1078-0432.Ccr-17-3509","volume":"24","author":"D Tamborero","year":"2018","unstructured":"Tamborero D, Rubio-Perez C, Muinos F, Sabarinathan R, Piulats JM, Muntasell A, Dienstmann R, Lopez-Bigas N, Gonzalez-Perez A. A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations. Clin Cancer Res. 2018;24(15):3717\u201328. \n                    https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-3509\n                    \n                  .","journal-title":"Clin Cancer Res"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"15081","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee HO, Lee KM, Lee HB, Kim KT, Ryu HS, Kim S, Lee JE, Park YH, Kan ZY, Han W, Park WY. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nature Communications. 2017;8:15081. \n                    https:\/\/doi.org\/10.1038\/ncomms15081\n                    \n                  .","journal-title":"Nature Communications"},{"key":"755_CR18","doi-asserted-by":"crossref","unstructured":"Szekely B, Bossuyt V, Li XT, Baine M, Silber A, Sanft T, Hofstatter E, Mougalian S, Baghwagar S, Neumeister V, Pelekanou V, Hatzis C, Pusztai L. Immunological differences between primary and metastatic breast cancer. Cancer Res. 2018;78(4):2232-239.","DOI":"10.1093\/annonc\/mdy399"},{"issue":"10","key":"755_CR19","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.humpath.2013.03.010","volume":"44","author":"A Cimino-Mathews","year":"2013","unstructured":"Cimino-Mathews A, Ye X, Meeker A, Argani P, Emens LA. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study. Hum Pathol. 2013;44(10):2055\u201363. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2013.03.010\n                    \n                  .","journal-title":"Hum Pathol"},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.humpath.2018.06.008","volume":"80","author":"O Tawfik","year":"2018","unstructured":"Tawfik O, Kimler BF, Karnik T, Shehata P. Clinicopathological correlation of PD-L1 expression in primary and metastatic breast cancer and infiltrating immune cells. Hum Pathol. 2018;80:170\u20138. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2018.06.008\n                    \n                  .","journal-title":"Hum Pathol"},{"key":"755_CR21","doi-asserted-by":"publisher","unstructured":"Williams CB, Yeh ES, Soloff AC. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer. 2016;2. \n                    https:\/\/doi.org\/10.1038\/npjbcancer.2015.25\n                    \n                  .","DOI":"10.1038\/npjbcancer.2015.25"},{"issue":"7355","key":"755_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li JF, Zhang H, Kitamura T, Zhang JH, Campion LR, Kaiser EA, Snyder LA, Pollard JW. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222\u2013U129. \n                    https:\/\/doi.org\/10.1038\/nature10138\n                    \n                  .","journal-title":"Nature"},{"issue":"1","key":"755_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41467-017-02481-5","volume":"9","author":"N Linde","year":"2018","unstructured":"Linde N, Casanova-Acebes M, Sosa MS, Mortha A, Rahman A, Farias E, Harper K, Tardio E, Reyes Torres I, Jones J, Condeelis J, Merad M, Aguirre-Ghiso JA. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun. 2018;9(1):21. \n                    https:\/\/doi.org\/10.1038\/s41467-017-02481-5\n                    \n                  .","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1136\/jitc-020-0755-1corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000}}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0755-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-019-0755-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0755-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:45:25Z","timestamp":1601041525000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0755-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0755-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/525071","asserted-by":"object"}]},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"assertion":[{"value":"23 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate were approved under the University of Pittsburgh IRB # PRO11100645, 14040193, 1500502, 1602030.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PKB receives Speaker\u2019s Honoraria from Genentech-Roche and Merck; research funding from Pfizer and Merck; and is a consultant in Eli Lilly, Merck, and Angiochem. CA receives research funding and serves an uncompensated advisory role for Novartis, Merrimack, Lily, Seattle Genetics, Nektar, Tesaro. CA receives research funding from Merck, Tesaro, PUMA, and G1-Therapeutics. CA has a compensated consultant role with Merck, PUMA and Eisai, and uncompensated advisory role with Genentech. CA receives royalties from UpToDate, Jones and Bartlett. ACS receives Susan G. Komen Foundation Career Catalyst Research award (CCR15329745). DAAV owns stock in TTMS, Tizona, Oncorus, BMS; patents licensed in Tizona, BMS, Astellas; grants from BMS; Scientific Advisory Board in Tizona, Oncorus, F-Star, Pieris; and consultancy in Crescendo, Intellia, MPM, Onkaido, Servier. LE reports grants and non-financial support from Roche\/Genentech, Corvu; grants and personal fees from AstraZeneca; grants from EMD Serono; personal fees from Syndax, Amgen, Medimmune, AbbVie, Gristone Oncology, Peregrine, Celgene, eTHeRNA; non-financial support from Bristol-Myers Squibb; grants, personal fees and non-financial support from Aduro Biotech, Bayer, Replimune, Novartis, Macrogenics, Vaccinex, Maxcyte; personal fees and other from Molecuvax; grants from Merck; and member, FDA Advisory Committee on Cell Tissue and Gene Therapies; member, Board of Directors for Society of Immunotherapy of Cancer. PCL owns stock in Amgen (AMGN) and his spouse KP-G has consulted for Bayer\/Loxo. KLB is an employee of Eli Lilly. SO is a member of the Scientific Advisory Panel for NSABP.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}